Long Molecule Footprints of Complex Cancer Genome Structure - Invited Presentation
Explore complex cancer genome structures through long molecule footprints. Gain insights into advanced genomic analysis techniques for accurate cancer diagnosis and personalized treatment.
Beyond CNVs: Leveraging SNP Arrays in Cancer
Explore leveraging SNP arrays in cancer genomics beyond CNVs, focusing on mosaic gains/losses, HRD scores, and noninformative SNPs for improved diagnosis and treatment.
NGS in the Clinical Laboratory - Experiences of the Holycross Cancer Center with One-Day NGS
Explore clinical NGS implementation at Holycross Cancer Center, focusing on challenges, solutions, and future directions in molecular diagnostics for cancer care.
Utilization of the Genexus Turnkey NGS Platform for Molecular Profiling of NSCLC Samples
Explore molecular profiling of NSCLC samples using the Genexus turnkey NGS platform with Dr. Brendan Pang, a consultant pathologist and medical director.
Making Your Research Translatable: The Example of RENACER
Explore translational research strategies through RENACER example, enhancing impact of scientific discoveries in clinical settings.
The Role of TRAIL in Premetastatic Niche Formation in Breast Cancer
Explore groundbreaking research on TRAIL's role in breast cancer metastasis, uncovering its function as a vascular gatekeeper and its therapeutic potential in preventing premetastatic niche formation.
Translating Human Readable Variation Descriptions to Unique Computable Variations with the Variation Normalizer
Learn to translate human-readable genetic variation descriptions into unique computable variations using the Variation Normalizer tool for improved cancer genomics analysis and diagnosis.
Two Co-occurring Driver Mutations in Primary Lung Adenocarcinoma - Who's Driving Treatment?
Explore co-occurring driver mutations in lung adenocarcinoma, their impact on RAS signaling, and implications for targeted therapies. Gain insights into clinical cases and treatment strategies.
Epigenetic Reprogramming of Brain Development Pathways During Non-Small Cell Lung Cancer Metastasis
Explore epigenetic reprogramming in brain development pathways during non-small cell lung cancer metastasis. Gain insights into cutting-edge cancer genomics research and its implications for diagnosis and treatment.
Computational Prediction of MHC Anchor Locations for Neoantigen Identification and Prioritization
Explore computational methods for predicting MHC anchor locations to enhance neoantigen identification and prioritization in cancer genomics, improving patient diagnosis and treatment.
Overcoming Challenges of Somatic RNA Variant Calling in Solid Tumors
Explore techniques for accurate somatic RNA variant calling in solid tumors, addressing key challenges and improving cancer genomics analysis.
Gene Regulation in Cellular Senescence
Explore gene regulation in cellular senescence with Prof. Masashi Narita, uncovering key insights on epigenetic aspects and senescence-associated heterochromatic foci (SAHFs).
Internalizing a Comprehensive Genomic Profiling Solution with a Path to Reimbursement
Explore comprehensive genomic profiling solutions for cancer diagnosis, focusing on internalizing processes, overcoming challenges, and securing reimbursement pathways.
Developing Next Generation Biomarkers - A New Approach
Explore innovative approaches to developing next-generation biomarkers for cancer diagnosis and treatment, enhancing precision medicine and patient outcomes.
Integrative Cytogenetic and Molecular Studies Unmasks Chromosomal Mimicry in Hematologic Malignancies
Explore integrative cytogenetic and molecular studies revealing 'Chromosomal Mimicry' in hematologic malignancies, enhancing accurate diagnosis and targeted therapy for cancer patients.
Utilizing Rapid Molecular Testing to Reduce Disparities in Pediatric Cancer in Sub-Saharan Africa
Explore rapid molecular testing strategies to address pediatric cancer disparities in Sub-Saharan Africa, focusing on improved diagnosis and treatment outcomes.
Frequency and Etiology of Cytogenetically Cryptic Oncogenic Fusions in Pediatric AML
Explore cytogenetically cryptic oncogenic fusions in pediatric AML, examining their frequency and etiology to enhance diagnostic accuracy and treatment approaches.
Cell-free DNA Genomic and Epigenomic Analysis to Predict Survival in mCRPC Patients
Explore genomic and epigenomic analysis of cell-free DNA to predict survival in metastatic castration-resistant prostate cancer patients undergoing AR-directed therapy.
Comparative Analysis of RNA Expression Identifies Druggable Targets in Pediatric Solid Tumors
Explore RNA expression analysis for identifying targetable therapies in challenging pediatric solid tumors, advancing precision medicine for young cancer patients.
ClinGen Cancer Variant Interpretation Committee - Pilot Guidance for Somatic Cancer Variant Curation
Explore pilot guidance for somatic cancer variant curation expert panels, focusing on best practices in clinical cancer genomics and accurate patient diagnosis.
Personalized Sequencing Assays for Cerebrospinal Fluid Liquid Biopsies in Children with Brain Tumors
Explore personalized sequencing techniques for cerebrospinal fluid biopsies in pediatric brain tumor cases, enhancing diagnostic and monitoring capabilities.